Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-08-19Clinical Trial Update: Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter Pylori [Phase 4]
A Phase 4 clinical trial evaluated the efficacy and safety of a 1-week triple therapy including ilaprazole for eradicating Helicobacter pylo…
-
CLINICAL_TRIALS research · 2016-08-16Clinical Trial Update: Epidemiology of Helicobacter Pylori Infection Among Shanghai Children
This completed clinical trial provides epidemiological data on Helicobacter pylori infection among children in Shanghai.
-
FDA approval · 2016-08-10FDA Approved: ESOMEPRAZOLE SODIUM — Original Application (Eugia US LLC)
FDA approved Eugia US LLC's original application for esomeprazole sodium, a generic proton pump inhibitor, confirming a generic version of t…
-
FDA approval · 2016-07-25FDA Approved: IDKIT HP ONE — Supplemental Application (Meridian Bioscience Israel Ltd)
The FDA approved a supplemental application for IDKIT HP ONE, a diagnostic test kit using 13C-urea for detecting Helicobacter pylori infecti…
-
FDA approval · 2016-07-25FDA Approved: LANSOPRAZOLE — Original Application (Xiromed LLC)
FDA approved the original application for a generic lansoprazole from Xiromed LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-07-18Clinical Trial Update: Efficacy and Safety of Ilaprazole Based Bismuth-containing Quadruple Regimen for the First-line Treatment of Helicobacter Pylori Infection [Phase 4]
Phase 4 trial assessing the efficacy and safety of an ilaprazole-based, bismuth-containing quadruple regimen as first-line treatment for Hel…
-
FDA approval · 2016-07-08FDA Approved: IDKIT HP ONE — Supplemental Application (Meridian Bioscience Israel Ltd)
FDA approved a supplemental application for IDKIT HP ONE, a diagnostic kit consisting of citric acid anhydrous and 13C urea, from Meridian B…
-
FDA approval · 2016-06-01FDA Approved: LANSOPRAZOLE — Original Application (Rite Aid Corporation)
FDA approved an original-application generic lansoprazole (a proton pump inhibitor) as an approved product; Rite Aid Corporation was the app…
-
CLINICAL_TRIALS trial_result · 2016-05-04Clinical Trial Update: Eradication of H. Pylori Therapy Individualized by the Mutation of 23S rRNA of H. Pylori [Phase 2]
A Phase 2 clinical trial update evaluating a Helicobacter pylori eradication therapy individualized by 23S rRNA mutations.
-
CLINICAL_TRIALS research · 2016-05-03Clinical Trial Update: Development of Treatment Algorithm for Eradication of Helicobacter Pylori Based on Antibiotic Susceptibility Test [NA]
A clinical trial update focusing on developing a treatment algorithm for eradicating Helicobacter pylori based on antibiotic susceptibility …
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Serum Zinc, Peptic Ulcer Disease and H. Pylori Infection
A completed clinical trial update examining the relationship between serum zinc levels and peptic ulcer disease in the context of Helicobact…
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Inflammation, Infection, and Future Cardiovascular Risk
This is a completed NHLBI clinical trial update examining how inflammation and infection relate to future cardiovascular risk. It discusses …
-
CLINICAL_TRIALS research · 2016-03-16Clinical Trial Update: Value of Additional Corpus Biopsy for Diagnosis of H Pylori in Atrophic Gastritis. Prospective Non-randomized Study [NA]
Prospective non-randomized study evaluating the added value of corpus biopsy for diagnosing Helicobacter pylori in atrophic gastritis.
-
CLINICAL_TRIALS trial_result · 2016-03-01Clinical Trial Update: High Dose Amoxicillin Versus Tetracycline as Second-line Treatment of Resistant Helicobacter Pylori Infection [Phase 4]
A Phase 4 trial comparing high-dose amoxicillin versus tetracycline as second-line therapy for resistant Helicobacter pylori infection has c…
-
FDA approval · 2016-02-26FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for the fixed-dose combination of bismuth subcitrate potassium, metronidazole, and tetracycline hydr…
-
FDA approval · 2016-02-25FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for omeprazole from Lannett Company, Inc., effectively updating the product labeling under the ANDA.
-
CLINICAL_TRIALS trial_result · 2016-02-25Clinical Trial Update: Comparison of the Eradications Rates of Sequential Therapy Versus Concomitant Therapy [Phase 4]
Phase 4 clinical trial comparing eradication rates of sequential therapy versus concomitant therapy for Helicobacter pylori infection.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Infection and Cardiovascular Disease
Clinical trial update indicating the NHLBI study on infections and cardiovascular disease has completed. The provided excerpt does not inclu…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori Infection [NA]
A completed clinical trial comparing a 12-day reverse hybrid therapy to a 12-day standard triple therapy for Helicobacter pylori infection; …
-
CLINICAL_TRIALS trial_result · 2016-02-04Clinical Trial Update: Reinfection After Eradication of Helicobacter Pylori Infection
This clinical trial update discusses reinfection after eradication of Helicobacter pylori infection and outlines monitoring of recurrence fo…
-
CLINICAL_TRIALS research · 2016-01-13Clinical Trial Update: Potential Adverse Developmental and Nutritional Consequences of Helicobacter Pylori Infection in Israeli Children
This clinical trial update discusses potential adverse developmental and nutritional consequences of Helicobacter pylori infection in Israel…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Tailored Therapy for Helicobacter Pylori in Children [Phase 4]
A Phase 4 clinical trial update describing a tailored therapy approach for Helicobacter pylori infection in children.
-
FDA approval · 2015-12-16FDA Approved: PREVACID — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for PREVACID (lansoprazole) submitted by Takeda Pharmaceuticals America, Inc. The approval updates t…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: S1119 Peruvian H. Pylori Water Contamination Study
The update indicates that the S1119 Peru study on Helicobacter pylori infection related to water contamination sponsored by SWOG Cancer Rese…
-
CLINICAL_TRIALS withdrawal · 2015-11-17Clinical Trial Update: Evaluation of SQ109 Plus PPI in Urea Breath Test-Positive Volunteers [Phase 2]
A Phase 2 trial evaluating SQ109 plus a proton pump inhibitor for Helicobacter pylori infection has been withdrawn.